Project Grant HT94252510232
Award Date
4/15/25
Completion Date
4/14/29
Dollars Obligated
$1.6M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tampa, FL 33612, USA
Similar Awards
The U.S. Department of Defense's Defense Health Agency awarded a $995,267 Project Grant (CFDA 12.420 - Military Medical Research and Development) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The grant supports a 4-year translational research program focused on advancing peer-reviewed cancer research through a collaborative team science approach. The award provides funding for innovative scientific studies across multiple medical disciplines...
The U.S. Department of Defense's Defense Health Agency awarded a $481,749 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 30, 2023 through September 29, 2026, will support research to dissect the spatial molecular architecture of the transformed cutaneous T cell lymphoma tumor microenvironment, with the goal of identifying...
The U.S. Department of Defense's Defense Health Agency has awarded a $762,168 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a project period from September 30, 2023 to September 29, 2026, is intended to "DECONVOLUTE KEY BIOLOGICAL DRIVERS THAT DEFINE SUBSETS OF LETHAL PROSTATE CANCER IN AFRICAN AMERICAN MEN." As a leading National Cancer...
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), has awarded a $328,575 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. This 3-year grant, with a start date of September 1, 2024, will support research aimed at "Reversing Exhaustion of Tumor-Infiltrating Lymphocytes for Improvement of Adoptive Cell Therapy." As a National Cancer Institute-designated comprehensive cancer...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $2,837,644 Project Grant to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The funding will support "Translational Studies for Targeted Alpha-Particle Therapy for Rare Melanomas" over a 4-year period from September 1, 2023 to August 31, 2027. This project grant aims to advance research into innovative cancer therapies, specifically...
This $168,500 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research efforts by H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Tampa, Florida. The award will fund a project titled "Cotargeting of Type 1 PRMT and YAP1 to Combat EGFR-Mutant Lung Adenocarcinoma" over the period of September 1, 2024 to August 31, 2025. The research aims to develop novel therapeutic approaches...
The Defense Health Agency awarded H. Lee Moffitt Cancer Center And Research Institute Hospital, Inc. $842,500 under the Military Medical Research and Development federal grant program (CFDA 12.420) to define the glycoproteome in melanoma progression from June 1, 2023 to May 31, 2026. Through this award, Moffitt Cancer Center will investigate medical solutions for melanoma on the battlefield by defining the glycoproteome, which are glycosylated RNA and proteins, and how their expression...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $697,590.00 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to evaluate B-T cell cross-talk within tertiary lymphoid structures in melanoma progression and immune checkpoint blockade. The award term is from July 1, 2024 to June 30, 2027. Moffitt Cancer Center is a non-profit, NCI-designated comprehensive cancer center that has...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative...
The H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. was awarded a $857,516 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund the development of adoptive T-cell therapy incorporating patient-specific tumor microenvironments to treat bladder cancer from September 1, 2022 to August 31, 2026. Through this funding, Moffitt Cancer Center will work to transform bladder cancer treatment by...